Vynleads, Inc.
VYND • Medical - Healthcare Information Services
$0.41
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$7.51M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.13Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:18 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.41
Change0.00%
Market Cap$7.51M
52W Range0.25 - 0.50
Beta5.05
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.47
Current Ratio0.13
Quick Ratio0.13
Revenue 5Y-100.00%
Price$0.41
Change0.00%
Market Cap$7.51M
52W Range0.25 - 0.50
Beta5.05
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.47
Current Ratio0.13
Quick Ratio0.13
Revenue 5Y-100.00%
Volume700.00
Avg Volume67.00
Investment DNA
How strong this company looks for long-term investors
30
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
45/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Weak liquidity · 0.13Negative growth trendWeak profitability
Analyst view
No analyst data available now.
Financial Health
Score9 / 20
Debt / Equity: -0.47
Current Ratio: 0.13
Quick Ratio: 0.13
Status: Moderate
Warnings
- Weak Liquidity
- Weak quick ratio
🧾
No insider activity
No recent insider transactions available.